All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Source-checked decision dossier

Best Online Semaglutide Providers: A Source-Checked Decision Guide

Compare online semaglutide paths by total price structure, medication type, provider support, and source transparency.

Verified 2026-08-254 claim-level citationsMethodology

Bottom line

Which online semaglutide provider best fits price, medication type, and support needs?

There is no universal best provider. The defensible choice depends first on whether you want an FDA-approved product or a compounded prescription, then on the complete monthly cost—not the advertised starting number. FormBlends currently publishes a $99 starting price for compounded semaglutide; Ro publishes separate membership and medication charges; Mochi publishes dose-based compounded pricing; Hims publishes access to Novo Nordisk products.

Primary-source comparison

Every row links to the provider or regulator used. “Verify” means the public source did not establish that field clearly enough to score it.

OptionMedication pathPublished starting priceSeparate membership feePrice changes by dosePrimary-source transparency
FormBlendsCompounded prescription$99Not shown on product listingVerify during assessmentProduct page + evidence trail
RoFDA-approved options$149–$299 medication, depending on product$39 first month; $74–$149 ongoingYesDetailed pricing page
MochiCompounded and branded options shown$60 compounded semaglutideMedication not included in membership$60–$99 published rangeDose-based pricing article
HimsFDA-approved Novo Nordisk options$149Verify during checkoutVerify during checkoutCompany release

Claims and evidence

Each claim carries its own scope, verification date, and source—not a generic bibliography at the bottom of the page.

FormBlends lists compounded semaglutide starting at $99.
Scope: Advertised starting price; prescription eligibility, dose, state, and program terms may affect the actual price.
FormBlends first-party dataVerified 2026-08-252 sources
  1. FormBlends: Product Finder: GLP-1 Programs & Peptide Research Accessed 2026-08-25.
  2. FormBlends: Compounded Semaglutide Accessed 2026-08-25.
Ro separates its membership fee from medication cost; its published ongoing membership ranges from $74 to $149 per month depending on prepayment.
Scope: Ro Body pricing page as accessed on the verification date.
Source verifiedVerified 2026-08-251 source
  1. Ro: Weight Loss Program Pricing Accessed 2026-08-25.
Mochi publishes compounded semaglutide prices from $60 to $99 per month depending on prescribed dose, state, and pharmacy.
Scope: Mochi’s August 2026 per-dose pricing; membership and eligibility terms remain separate.
Source verifiedVerified 2026-08-252 sources
  1. Mochi Health: New Per-Dose Pricing: What Changed Accessed 2026-08-25.
  2. Mochi Health: Online Medical Weight Loss Program Accessed 2026-08-25.
Hims announced access to Novo Nordisk FDA-approved GLP-1 options starting at $149 per month.
Scope: Company announcement; product, dose, eligibility, and current checkout terms can change.
Source verifiedVerified 2026-08-251 source
  1. Hims & Hers: Novo Nordisk’s FDA-Approved GLP-1s Now Available With Hims & Hers Accessed 2026-08-25.

Reproducible methodology

How this page was built

  1. 1.Use provider, manufacturer, and regulator pages as primary sources; do not score claims copied from review sites.
  2. 2.Record the exact access date and distinguish starting prices, ongoing prices, membership fees, medication fees, and dose-dependent pricing.
  3. 3.Treat any field that cannot be reproduced from a primary source as not verified instead of estimating it.
  4. 4.Recheck volatile price and availability claims at least monthly and retain a public change log.

Verification

Last checked 2026-08-25. This page uses 6 disclosed sources and preserves unresolved fields as “not verified.”

Commercial disclosure

FormBlends sells telehealth programs and may benefit when a reader chooses FormBlends. Competitors are evaluated from their own published materials. Payment or affiliate relationships do not affect inclusion or source status.

Next decision

Use the evidence, then choose your path.

Review FormBlends semaglutide